5 Analysts Have This to Say About Outset Medical
Portfolio Pulse from Benzinga Insights
Outset Medical (NASDAQ:OM) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, 2 indifferent, and 1 somewhat bearish rating. The average 12-month price target for OM is $7.3, representing a significant decrease from the previous target of $22.20. This new target suggests a potential downside of 67.12% from the earlier projections.
December 04, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's average price target has been significantly reduced to $7.3, indicating a potential downside of 67.12% from the previous target of $22.20, reflecting a negative sentiment among analysts.
The revised average price target is substantially lower than the previous one, which suggests that analysts have become more bearish on the stock. This could lead to a negative short-term impact on Outset Medical's stock price as the market digests the new information and adjusts its expectations.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100